Singulair (Leukotriene Modifiers) Step Therapy Program

Singulair, Accolate, and Zyflo CR are Leukotriene Modifiers. These drugs are used to treat asthma and allergies.

New Prescriptions After July 1, 2007

This is how the program works for new Leukotriene Modifiers prescriptions for members who do not have a diagnosis for asthma.

Drugs Affected

• Singulair
• Accolate
• Zyflo CR

For Leukotriene Modifiers to be a covered benefit for members 18 and older who do not have a diagnosis for asthma, you must follow these steps:

• You must try and fail BOTH a non-sedating antihistamine and a nasal corticosteroid to receive a Leukotriene Modifier for the treatment of allergies (allergic rhinitis)

If your doctor wants you to “skip” steps, your doctor will need to submit a prior authorization request and receive approval for the drug to be covered.

Copyright© 2008 Wellmark, Inc. All Rights Reserved.
Wellmark Blue Cross and Blue Shield is an Independent Licensee of the Blue Cross and Blue Shield Association. Blue Cross®, Blue Shield®, and the Cross® and Shield® symbols are registered marks of the Blue Cross and Blue Shield Association, an Association of Independent Blue Cross and Blue Shield Plans.